Clinical Trials Logo

Parkinson's Disease Psychosis clinical trials

View clinical trials related to Parkinson's Disease Psychosis.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT02762591 Approved for marketing - Clinical trials for Parkinson's Disease Psychosis

Expanded Access of Pimavanserin for Patients With PD Psychosis

Start date: n/a
Phase: N/A
Study type: Expanded Access

The purpose of this program is to provide patients with PDP access to pimavanserin until the product receives marketing approval from the FDA and is commercially available.